Browse
FDA applications
Approved and filed applications connected to their products and owning companies.
29,787 results
| Application | Applicant | Application number |
|---|---|---|
| BLA 021106 | Pharmacia & Upjohn Company LLC | BLA021106 |
| BLA 021148 | Novo Nordisk Inc. | BLA021148 |
| BLA 021149 | EMD Serono, Inc. | BLA021149 |
| BLA 021172 | Novo Nordisk Inc. | BLA021172 |
| BLA 021211 | Organon USA LLC, a subsidiary of Organon & Co. | BLA021211 |
| BLA 021271 | Bausch Health US, LLC | BLA021271 |
| BLA 021273 | Organon USA Inc., a subsidiary of Merck & Co., Inc. | BLA021273 |
| BLA 021289 | Ferring Pharmaceuticals Inc. | BLA021289 |
| BLA 021426 | Sandoz Inc. | BLA021426 |
| BLA 021484 | FERRING | BLA021484 |
| BLA 021536 | Novo Nordisk Inc. | BLA021536 |
| BLA 021538 | Emergent Biosolutions Canada Inc. | BLA021538 |
| BLA 021597 | EMD SERONO | BLA021597 |
| BLA 021629 | Sanofi-Aventis U.S. LLC | BLA021629 |
| BLA 021640 | Bausch & Lomb Incorporated | BLA021640 |
| BLA 021663 | Ferring Pharmaceuticals Inc. | BLA021663 |
| BLA 021665 | Amphastar Pharmaceuticals, Inc. | BLA021665 |
| BLA 021684 | EMD Serono, Inc. | BLA021684 |
| BLA 021716 | Akorn, Inc. | BLA021716 |
| BLA 021765 | EMD Serono, Inc. | BLA021765 |
| BLA 021810 | Novo Nordisk Inc. | BLA021810 |
| BLA 021839 | Eton Pharmaceuticals, Inc. | BLA021839 |
| BLA 021846 | Microbix Biosystems Inc. | BLA021846 |
| BLA 021859 | Halozyme Therapeutics, Inc. | BLA021859 |
| BLA 021878 | NOVO NORDISK | BLA021878 |
| BLA 021884 | Insmed Incorporated | BLA021884 |
| BLA 022175 | Digestive Care, Inc. | BLA022175 |
| BLA 022210 | Aimmune Therapeutics, Inc. | BLA022210 |
| BLA 022458 | Pfizer Inc. | BLA022458 |
| BLA 022472 | Mannkind Corporation | BLA022472 |
| BLA 022505 | Theratechnologies Inc. | BLA022505 |
| BLA 022523 | VIVUS LLC | BLA022523 |
| BLA 022542 | Viokace, LLC | BLA022542 |
| BLA 022575 | Takeda Pharmaceuticals U.S.A., Inc. | BLA022575 |
| BLA 050114 | AllerQuest, LLC | BLA050114 |
| BLA 050294 | Parke-Davis, a Division of Pfizer Inc. | BLA050294 |
| BLA 101062 | Merck Sharp & Dohme LLC | BLA101062 |
| BLA 101063 | Recordati Rare Diseases, Inc. | BLA101063 |
| BLA 101066 | Merck Sharp & Dohme LLC | BLA101066 |
| BLA 101068 | Merck Sharp & Dohme LLC | BLA101068 |
| BLA 101069 | Merck Sharp & Dohme LLC | BLA101069 |
| BLA 101072 | Merck Sharp & Dohme LLC | BLA101072 |
| BLA 101075 | Merck Sharp & Dohme LLC | BLA101075 |
| BLA 101084 | Merck Sharp & Dohme LLC | BLA101084 |
| BLA 101094 | Merck Sharp & Dohme LLC | BLA101094 |
| BLA 101098 | Wyeth Pharmaceuticals LLC | BLA101098 |
| BLA 101099 | Wyeth Pharmaceuticals LLC | BLA101099 |
| BLA 101130 | Grifols Therapeutics LLC | BLA101130 |
| BLA 101134 | Grifols Therapeutics LLC | BLA101134 |
| BLA 101138 | Grifols Therapeutics LLC | BLA101138 |